Form 4: LifeMD's Chief Technology Officer, Dennis Wijnker, Reports Transaction
SEC Form 4 Filing
Dennis Wijnker, Chief Technology Officer of LifeMD, Inc., reports a transaction involving the acquisition and disposal of common stock.
Summary
- On March 31, 2025, Dennis Wijnker, the Chief Technology Officer of LifeMD, Inc., acquired 25,000 shares of common stock.
- These shares were acquired at a price of $0.
- On the same day, Wijnker disposed of 150,000 shares.
- The transaction was reported on April 2, 2025.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock transaction. The sentiment is neither positive nor negative without additional context.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's important for investors to monitor such filings to understand management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders like the Chief Technology Officer.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of stock acquisition and disposal |
| 04/02/2025 | Date of Form 4 filing |
Keywords
LifeMD, LFMD, Dennis Wijnker, Chief Technology Officer, Form 4, SEC, Beneficial Ownership, Stock Transaction, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.